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Background: Major changes in gene expression occur in the fetal brain to modulate the function of this organ
postnatally. Thus, factors can alter the genomics of the fetal brain, predisposing to neurological disorders later in
life. We hypothesized that the physiological dynamics of the immune system transcriptome of the fetal brain
during the last stage of gestation will reveal patterns of immune function and development in the developing
brain. In this study we applied weighted gene co-expression analysis of microarrays performed on ovine fetal brain
samples, to model the changes in gene expression throughout the second half of gestation.
Results: Clusters of co-expressed genes that strongly increase in expression toward the first day of extra-uterine
life are related to the hematopoietic lineage, while activation of immune pathways is induced after birth. Moreover,
the pattern of gene expression suggests induction of tolerance mechanisms, probably necessary to protect highly
produced proteins –such as myelin basic protein- from an autoimmune attack.
Conclusions: This study provides insight into the dramatic changes in gene expression that take place in the brain
during the fetal life, especially during the last stage of gestation, and suggests that the immune system may have
an important role in maturation of the fetal brain, which if disrupted or altered, could have negative consequences
in postnatal life.Background
Normal brain development requires temporal changes in
gene expression. In the human brain, the major changes
in spatio-temporal gene expression occur during the late
gestation fetal life [1]. Little is known about development
of immune function in the fetal brain, although there is
a growing literature that some chronic diseases of the
adult, such as hypertension [2], schizophrenia [3], and
autoimmune disorders [4] are at least in part the result
of immune dysfunction within the brain. Several studies
have analyzed the effect of diverse stimuli (such as nutri-
tion, stress, toxics and so on) on the activity of the immune
system in the fetal brain and the repercussions in adulthood
(reviewed in [5,6]). Despite its importance, the ontogeny of
immune cells within the fetal brain is not fully understood.
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unless otherwise stated.gestation has been on development of these cells in somatic
sites (i.e., liver, thymus, spleen, etc.). However, a better un-
derstanding of the molecular development of the immune
system within the brain holds promise for design of novel
therapeutics that can redirect the “programmed” brain back
to a normal trajectory of development. The purpose of the
present study is to model changes and coherence of gene
expression in cerebral cortex, brainstem, hippocampus, and
hypothalamus in order to obtain a broad view of brain
ontogeny throughout the second half of gestation. We
found, in addition to expected changes in pathways related
to brain structure and metabolism, that there was an
over-representation of genes in the hematopoietic pathway.
We therefore modeled the changes in genes in the
hematopoietic pathway over this period of ontogeny. We
expect that the study of genomics related to immune
system development in late gestation fetal brain might
reveal molecular mechanisms of neuronal protection. More-
over, investigation of the genomics of fetal brainral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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anisms underpinning postnatal neurological disorders.
We used the sheep as an animal model to identify co-
expressed genes in the above regions of the ovine fetal
brain, from mid-gestation (80 days, n = 4; 100 days, n = 4;
120 days, n = 4; 130 days, n = 4; 145 days, n = 4) to one
day of postnatal life (n = 4). In the ewe, gestation length
averages 147 days. The ovine fetus is an excellent model
to study brain development since the entire gestational
equivalent of human brain development occurs in utero
[7]. Altricial species (such as rats and mice) are not suit-
able models for human brain development because of the
marked immaturity of the brain at birth in these species.
Using a newly-available ovine array and weighted gene co-
expression network analysis (WGCNA) on differentially
expressed genes (Additional file 1: Figure S1), we identi-
fied co-expressed genes in different regions of the ovine
fetal brain, from mid-gestation to one day of postnatal life.
WGCNA determines pair-wise correlations between gene
expression profiles to create modules (clusters) of co-
expressed genes (Additional file 2: Figure S2). The result-
ing modules for each network were related with gesta-
tional age to determine gene significance (GS, correlation
of i-th gene with the temporal pattern) and module mem-
bership (MM; correlation of the i-th gene with respect to
its corresponding module) for each gene (Additional file 3:
Table S1 and Additional file 4: Figure S3). Top modules
were defined as those having the highest positive or
negative correlation between GS and MM; i.e., modules
with highest increasing or decreasing expression pattern
from mid-gestation to 1 day of extra-uterine life (Additional
file 5: Figure S4). These modules (or gene clusters) were
selected for further analyses.
Results and discussion
Enrichment and network analysis
Significantly enriched Biological Processes (BP; p < 0.01;
WebGestalt software [8]) of the positively correlated top
modules from each brain region are shown in Additional
file 6: Table S2. Negatively correlated top modules were
mainly enriched with cell cycle. In agreement with other
studies [1,9], groups of co-expressed genes that increase
in expression toward the end of gestation are related with
response to stress and stimulus, myelination, apoptosis,
generation of energy, and angiogenesis, while genes that
decrease in expression are mainly related to cell cycle.
These events occur because during the last steps of
fetal brain development there is a deceleration in cell
division (quiescence) simultaneous with an acceleration
in neuronal developmental and differentiation [9-11].
Significantly enriched KEGG pathways (p < 0.01;
WebGestalt software [8]) were compared to identify
common enriched pathways between all brain regions
(Table 1). Some of the common enriched pathways inthe positively correlated top modules were expected in the
developing fetal brain, such as those related with metabol-
ism. Genes related with endocytosis and lysosomal activity
were also expected to be expressed at increasing levels by
the end of gestation, since they are particularly relevant in
polarized cells like the neurons [12]. Notably, a common
enriched KEGG pathway related with the immune func-
tion was the hematopoietic cell lineage. We focused
further analysis on genes related with the hematopoietic
lineage. These genes were visualized as separate networks,
according to the brain region, using the Cytoscape
software (3.0) [13] and physical and genetic interactions
between genes were inferred by use of the GeneMania
plugin [14] (Figure 1). Then, these networks were merged
together to obtain a single network connecting the nodes
corresponding to the genes of interest from the four brain
regions. The nodes (genes) that comprise this new
network represent markers for different immune cells and
at different stages of maturation. Therefore, the whole
network can be correlated with the hematopoietic lineage
(Figure 2), as was indicated by the “hematopoietic cell
lineage” as a common enriched KEGG pathway.
These results do not necessarily mean that the brain is
a hematopoietic organ similar to liver or spleen during
fetal life. Nor can it be concluded from this study that
hematopoietic stem cells are present in the ovine fetal
brain. Rather, these results strongly suggest the presence
of developing myeloid and lymphoid derived cells in
different regions of the fetal brain (vide infra).
Detailed analysis of immune marker genes
Marker genes for progenitor immune cells were found
in the top positive correlated module of the ovine fetal
brainstem. These markers are CD34, CD109 CD44, CD5
and CD9 (Additional file 7: Figure S5). CD109 antigen is
expressed by a subpopulation of CD34+ Hematopoietic
stem cell (HSC) and progenitor cells in the fetal and adult
bone marrow [15]. An isoform of CD44 is expressed on
CD34+ cells: HSC and progenitor cells [16]. Progenitors
cells of the myeloid lineage, such as colony-forming unit
macrophage/dendritic cells, express the colony stimulating
factor 1 receptor (CSF1R) for differentiation. The resident
myeloid inflammatory cells of the central nervous system
(CNS) parenchyma are microglial cells. Thus, expression
of CSF1R seems critical for microglia development. In
mice, the absence of CSF1R (Csf1r −/−) results in essen-
tially no macrophages/microglia (<99% depletion) in the
embryonic and early post-natal brain [17]. In mice, inter-
leukin 34 (IL34) binds to the CSF1R receptor with high af-
finity to regulate myeloid development and it can
substitute for colony stimulating factor 1 (CSF-1) in vivo.
IL34 is more highly expressed than CSF-1 mRNA in most
of the regions of the developing brain [18]. These genes
were part of the top positive correlated module in the
Table 1 Significantly enriched KEGG pathways in positive correlated top modules from all fetal brain regions
Adjusted p-values
KEGG Pathway Cortex Brainstem Hippocampus Hypothalamus
Endocytosis 2.42E-10 5.68E-08 0.0006 0.0013
Hematopoietic cell lineage 0.0027 0.0026 0.0002 0.0098
Insulin signaling pathway 3.11E-08 0.0003 0.0007 0.0016
Lysosome 7.19E-16 8.09E-08 0.0005 0.0001
MAPK signaling pathway 9.06E-09 0.0012 0.0006 0.0002
Metabolic pathways 7.12E-36 3.47E-26 0.0001 5.40E-16
Phagosome 2.37E-06 1.07E-07 6.00E-06 0.0004
Tight junction 5.29E-05 0.0014 0.0006 0.0004
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presenting cells, including CD1D, integrin, alpha M
(CD11B) and CD81, (Additional file 8: Figure S6) indicat-
ing the development of microglia in the fetal CNS
parenchyma.Figure 1 Networks composed by nodes (genes) related to the hemato
the top positively correlated module for each brain region. Grey nodes are
brainsteam (B), hippocampus (C) and hypothalamus (D).Interestingly, genes related to hematopoiesis increased in
expression during fetal life, but genes related to immune
system activation and antigen presentation are strongly
induced after birth (Figure 3A). These genes are those
encoding for the mayor histocompatibility complex class Ipoiesis in the ovine fetal brain. Black nodes are genes belonging to
genes inferred by the GeneMania plugin. Brain regions are cortex (A),
Figure 2 The nodes (genes) of the merged network represent markers for immune cells of the hematopoietic lineage. HSC, Hematopoietic
stem cell; MPP, multipotent progenitor; LMPP, lymphoid-primed multipotent progenitor; CLP, common lymphoid progenitor; GMP, granulocyte
macrophage progenitor. Hematopoiesis figure reprinted with permission from the Nature Publishing Group. (Source: Welinder and Murre, 2011. Ldb1,
a new guardian of hematopoietic stem cell maintenance. Nature Immunology, Vol 12:2. Figure 1, page 113).
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DMA and HLA-DRB1 (class II), or genes encoding for
components of the immunoproteosome necessary to process
class I MHC peptides, such as PSMB8 and PSMB10.
Therefore, these results suggest a regulated develop-
ment of the immune system in the fetal brain. In agree-
ment with this concept, mRNA expression of genes
markers for mature T-cells including the three chains of
the CD3 marker (CD3G-CD3E-CD3D) were stronglyFigure 3 Trajectories of gene expression for immune related genes. (
expression along fetal age and first day of extrauterine life –day 160-(solid
strongly induced after birth (dashed line, open diamond). (B) Opposite traj
gene (solid line, filled circle).increased after birth in the ovine fetal hippocampus,
when measured by RT-PCR (Additional file 9: Figure
S7), rising the possibility that T cells are present in the
fetal brain.
Circulating lymphoid cells could trespass the relatively
permeable blood brain barrier (BBB) during fetal life and
reach the brain parenchyma [19]. If any of these cells
escape central tolerance, it is possible for them to react
against highly antigenic self-proteins which are producedA) Genes related with the hematopoietic lineage are increased in
line, filled circles). Genes related with immune system activation are
ectory expression of CD24 gene (dashed line, open diamond) and MBP
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genic myelin basic protein (MBP) causing the autoimmune
demyelinating disease of the CNS known as multiple
sclerosis or in the animal model, experimental auto-
immune encephalitis (EAE) [20].
Expression of MBP gene was strongly positively corre-
lated with fetal age for all brain regions. Correlations
ranged from 0.87 in hippocampus to 0.92 in cortex, with
an average of 0.893. The gene encoding for MBP was one
of the top positive correlated modules for all brain regions
but also showed a strong increasing mRNA expression
measured by RT-PCR in the ovine fetal cortex (Additional
file 10: Figure S8A). Consequently, resident cells of the
CNS should be able to counteract the action of potential
auto-reactive lymphocytes.
Remarkably, an immune marker gene that was part of
the top negatively correlated modules for all brain
regions was CD24. Correlations of this gene with fetal
age ranged from −0.83 in hippocampus to −0.98 in
cortex (average −0.895). Thus, the expression trajectory
for this gene was the opposite of MBP (Figure 3B).
mRNA expression of this gene, as measured by RT-PCR
in ovine fetal cortex was dramatically decreased with fetal
age (Additional file 10: Figure S8B). CD24 is a surface
glycoprotein that is strongly expressed by immature
B- and T- lymphocytes, but which disappears from T cell
surface as T cell mature. However, activation of T cells re-
sulted in a rapid induction of CD24 expression [21]. CD24
is also expressed on resident cells of the CNS [22] and it is
able to inhibit the proliferation of immature neurons [23].
Expression of CD24 in both T cells and non-T host cells
is required for the development of EAE [24]. Expression of
CD24 in T cells actively inhibits clonal deletion (necessary
for central tolerance) allowing the expansion of autoreactive
T cells [25]. Expression of CD24 in the CNS resident cells,
including microglial cells and astrocytes, costimulates mye-
lin antigen specific T cells and promotes their effector func-
tion, promoting the autoimmune inflammation in the CNS
[26]. Taken together, these data imply that CD24 is involved
in the autoimmune reaction to myelin antigens.
Microglia cells are able to acquire a dendritic cell pheno-
type and mediate peripheral tolerance to avoid progression
of EAE [27]. Moreover, protection from EAE development,
mediated by dendritic cells, was exclusively associated with
low expression of CD24, when compared to EAE controls
[28]. Thus, we speculated that the strong downregulation
of CD24 with advancing fetal age results in a tolerance
mechanism necessary to avoid an autoimmune reaction to
myelin antigens, such as MBP, which could be related to
the susceptibility to this type of disease later in life.
Accordingly, genes related with immune tolerance
followed a pattern of increasing expression in late gestation.
The Fc fragment of IgG, low affinity IIb, receptor
(FCGRIIB) for example, is an inhibitory receptor onmyeloid cells that can regulate T cell tolerance and pro-
motes T-regulatory cell induction by increasing interleukin
10 (IL10) production [29,30]. Both IL10 and transforming
growth factor, beta 1 (TGFb), another cytokine involved in
T-regulatory cell induction, showed an increased expres-
sion in the cortex with fetal age as measured by micro-
array and qRT-PCR (Additional file 10: Figure S8C).
Conclusions
This study provides insight into the dramatic changes in
gene expression that take place in the brain during the
fetal life, especially during the last stage of gestation.
Results from the present study propose a regulated
development of the immune system in the ovine fetal brain.
This concept implies induction of tolerance mechanisms,
to protect fetal myelin from a possible autoimmune attack,
and activation of the immune response after birth, which
could be part of the physiological adaptation of the new-
born for the extrauterine life. These findings could provide
the basis for new investigation in this area, in order to
understand key regulators of fetal brain development.
Methods
Tissue collection
Tissues were collected from fetuses at 80 (80 d, n = 4),
96–100 (100 d, n = 4), 120 (120 d, n = 4), 130 (130 d, n = 4),
and 142–144 (145 d, n = 4) days of gestation and on the
first (1 d, n = 4) day after delivery. Each group included one
set of twin fetuses. None of the ewes showed any signs of
impending labor. For collection of fetal tissues, ewes were
killed with 20 ml of Euthasol solution (7.8 g pentobarbital
and 1 g phenytoin sodium; Virbac AH, Fort Worth, TX)
administered intravenously, the fetus was quickly removed,
and the fetal brain was removed. Brain dissection was per-
formed immediately, using sterile instruments and gloves.
First, the head was separated from the backbone cutting
cranial to the axis of the vertebrae. Second, the posterior
cranial bones were separated using forceps. With a scalpel
we cut the pituitary stalk and optic nerves to release the
brain, which was then deposited onto a sterile container or
surface. Holding the brain upside down, the hypothalamus
was dissected, followed by both hippocampi and the brain-
stem. Finally, a section of the frontal cortex was dissected.
Fetal tissues were rapidly frozen in liquid nitrogen and
stored at −80°C.
The use of animals in this project was approved by the
University of Florida Institutional Animal Care and Use
Committee.
RNA extraction and preparation
RNA was extracted from the cortex, hippocampus,
hypothalamus and brainstem using Trizol (Invitrogen,
Carlsbad, CA) and following the manufacturer’s direc-
tions. The RNA was resuspended in RNAsecure, and
Rabaglino et al. BMC Genomics 2014, 15:1001 Page 6 of 9
http://www.biomedcentral.com/1471-2164/15/1001stored at −80°C in aliquots until use. For microarray
analysis, 20 ug of RNA was DNase treated using the
Turbo RNase-free DNase kit (Ambion, Foster City, CA),
the concentration determined with a Nanodrop spectro-
photometer (ND-1000, ThermoFisher, Wilmington DE)
and the integrity of the RNA was measured using an Agi-
lent Bioanalyzer, 2100 model. One μg of the DNase-
treated RNA was labeled with Cyanine 3 (Cy3) CTP with
the Agilent Quick Amp kit (5190–0442, New Castle, DE)
according to their methodology, purified with the Qiagen
RNeasy kit (Valencia, CA) as according to Agilent’s revi-
sion of the Qiagen protocol as shown in the Quick Amp
kit protocol except that the microcentrifugation spins
were performed at room temperature instead of 4°C. The
resulting labeled cRNA was analyzed with the Nanodrop
spectrophotometer, and the specific activities and the
yields of the cRNAs were calculated. The labeled cRNA
was stored at −80°C until use.
Microarray hybridization
This was performed following protocols from Agilent.
Briefly, 600 ng of each labeled cRNA was fragmented and
then mixed with hybridization buffer using the Agilent
gene expression hybridization kit. These were applied to
sheep 8 × 15 K array slides (Agilent 019921), containing 8
arrays with 15,208 oligomers with a length of 60 bases and
hybridized at 65°C for 17 h at 10 rpm. A total of 3 slides
(24 arrays) were employed per each brain region (six
gestational ages times four replicates per gestational age).
The arrays were washed, dried, stabilized, and scanned
with an Agilent G2505B 2 dye scanner at the Interdiscip-
linary Center for Biotechnology Research at the University
of Florida. Features were extracted with Agilent Feature
extraction 9.1 software.
Microarray data
The limma package was employed to import the raw data
into R (http://www.r-project.org), perform background
correction and normalize the data using the quantile
normalization method [31]. Control probes and low
expressed probes were filtered out, retaining for further
analysis the probes that were at least 10% brighter than
the negative controls on at least four arrays.
Statistical analysis
The Bayesian Estimation of Temporal Regulation
(BETR) algorithm was used to identify the differentially
expressed genes (DEG) for each brain region at a False
Discovery Rate (FDR) < 0.05. The first gestational age
(80 days) was considered as baseline measurement and
compared to the subsequent time points, to correlate
the differential expression between time points. The al-
gorithm was applied using the BETR package for R soft-
ware. A detailed explanation of the mathematical modelcan be found in Aryee et al. [32]. This method returns
the probabilities of differential expression for each gene
in the data set. Genes with a probability higher than
99.99% were considered as DEG.
Supervised weighted gene co-expression network
analysis (WGCNA)
The DEG for each brain region was subjected to signed-
WGCNA. Rows of each data set were collapsed forming
an average expression of the genes with the same official
symbol, in order to obtain unique identifiers for each gene
in the working data set. The automatic method was
employed for block-wise network construction and
module detection. The co-expression similarity was raised
to a soft thresholding power (β) of 12 to calculate adja-
cency. The adjacency for the signed network is defined as
aij = |(1 + cor(xi,xj))/2|
β [33]. The resulting modules for
each network were related with the gestational age to
identify modules, or clusters, of co-expressed genes with
increasing or decreasing expression pattern. Gene signifi-
cance (GS) was defined as the correlation of i-th gene with
a temporal pattern. Module membership (MM) was
defined as the correlation of the i-th gene respects its
corresponding module (the higher is the MM the more
connected is the i-th gene with the other genes of the cor-
responding modules). The correlation coefficient of MM
and GS was measure for each module, plotting MM ver-
sus GS. Higher correlation between MM and GS means
that genes that are highly associated with the temporal
pattern are also the central elements of the given module
[33] (Additional file 3: Table S1). Modules that showed the
highest correlation between MM and GS, either with
increasing pattern (positive GS) or decreasing pattern
(negative GS), were selected for Enrichment analysis. The
top positively correlated module for each brain region
was: the turquoise module for cortex and brainstem, the
brown module for hippocampus and the blue module for
hypothalamus. The top negatively correlated module for
each brain region was: the blue module for cortex and
brainstem, the yellow module for hippocampus and the
turquoise module for hypothalamus (Additional file 4:
Figure S3).
All the analyses were performed with the WGCNA
package for R software. More details about the methodology




The bioinformatics tool applied for this purpose was
WebGestalt (WEB-based GEne SeT AnaLysis Toolkit).
This program is designed for functional genomic studies
that generate large number of gene list. Then, it organizes
the large set of genes based on common functional
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[8]. The list of human official symbols for the genes com-
posing the top modules for each network was submitted
for enrichment biological processes and KEGG pathway
analysis, selecting H. Sapiens as the organism of interest.
The statistical method employed was the hypergeometric
test, adjusting the p-values for Benjamini & Hochberg
method, selecting the minimun of 5 genes per category
and using the human genome as reference set. Signifi-
cantly enriched Kegg pathways (p < 0.01) were compared
to identify common enriched pathways between all brain
regions.
Network analysis
A gene network was constructed for each brain region
using CytoScape version 3.0 [13] through the GeneMania
plugin [14], which was used to infer network data. The set
of functional association data between genes was down-
loaded from the Homo sapiens database. The list of
human official symbols for the genes of interest was input
into the GeneMania plugin to retrieve the corresponding
association network. The association data employed was
protein-protein and protein-DNA interaction. Then, the
resulting networks were merged together using the Merge
Networks tool of Cytoscape 3.0.
Quantitative Real-Time (qRT)-PCR Validation
The mRNA samples extracted from the four brain
regions at the six different gestational ages (4 fetuses/
gestational age; 96 samples in total) were converted to
cDNA with a High Capacity cDNA Archive kit using the
methodology recommended by the kit manufacturer
(Applied Biosystems, Foster City, Calif., USA). The newly
synthesized cDNA was stored at −20°C until qRT-PCR
was performed.
A total of 18 genes were selected for further validation
by qRT-PCR. The cDNA from corresponding brain re-
gion was used to measure the mRNA of the following
genes: Brainstem: CD34, CD109, CD44, CD5 and CD9;
Hippocampus: CD3 gamma (CD3G), CD3 delta (C3D)
and CD3 epsilon (CD3E); Cortex: CSF-1 CSF1R, IL34,
CD11B, CD81, FCGRIIB, IL10, TGFB, CD24 and MBP.
Relative expression of selected genes were determined
using primers (Sigma-Aldrich, St Louis, MO) and Sybr
Green PCR Master Mix (Applied Biosystems, Foster City,
CA). Primers were designed with Primer Express software
(Applied Biosystems. Primers for CD109, CD44, CSF1,
CSF1R, IL34, CD24 and MBP were designed from the
corresponding bovine mRNA. Primers for CD34, CD5,
CD9, CD3G, CD3D, CD3E, CD81, CD11B, FCGR2B, IL10
and TGFB were designed from the ovine mRNA. Primers
sequences and accession numbers are reported in
Additional file 11: Table S3. All primer pairs had effi-
ciencies greater than 95%. The abundance of B-actinmRNA was determined in each brain region sample, using
primers and VIC Taqman probes designed from the ovine
B-actin sequence and Taqman qRT-PCR master mix
(Applied Biosystems, Foster City, CA). All samples were
run in triplicate for each gene and for B-actin. Relative
mRNA expression of each gene was calculated by deter-
mining change in threshold cycle (ΔCt) between the mean
Ct for each gene and the mean Ct for B-actin mRNA from
the same sample. The effect of gestational age on each
gene was analyzed by ANOVA using the ΔCt values. Pair-
wise comparisons among gestational age means were done
by Duncan’s procedure. Data were graphed as the mean
fold change in mRNA relative to the 80d group; fold
change in each sample was calculated as 2-ΔΔCt, where
ΔΔCt is the difference between ΔCt in each sample and
the mean ΔCt in the control group. For all statistical ana-
lyses, the criterion for achieving statistical significance was
P < 0.05.
Additional files
Additional file 1: Figure S1. Venn Diagram of the number of
differentially expressed genes (DEG) in the ovine fetal brain. DEG were
selected as those following a temporal profile during the last stage of
gestation in different regions of the ovine fetal brain.
Additional file 2: Figure S2. Weighted gene co-expression network
analysis (WGCNA) of the ovine fetal brain. WGCNA identifies modules of
co-expressed genes following an increasing or decreasing expression
temporal pattern during last stage of gestation in ovine fetal cortex
(A), brainstem (B), hippocampus (C) and hypothalamus (D). Modules are
colored according the number of genes contained in the module. For
example, the module’s color is turquoise if contains the largest number
of genes.
Additional file 3: Table S1. Modules attributes for each brain region.
Modules were determined by weighted gene-coexpression analysis on
each brain region of the ovine fetal brain. Gene significance (GS) with the
temporal pattern (Gestational Age) and module membership (MM) on
each module (and respective p-value) was determined for each differentially
expressed gene.
Additional file 4: Figure S3. Relationship between modules identified
in weighted gene co-expression networks and fetal age. The modules
were determined in fetal cortex (A), brainstem (B), hippocampus (C) and
hypothalamus (D). Positive correlations are showed in red and negative
correlations in blue. The stronger the color the higher the correlation
index.
Additional file 5: Figure S4. Module membership versus gene
significance plots. Modules composed by highly connected genes with
the highest positive or negative correlation with gestational age and the
respective dendrogram, identified en network analysis from the ovine
fetal cortex (A), brainstem (B), hippocampus (C) and hypothalamus (D).
Each plot is colored according the corresponding module.
Additional file 6: Table S2. Enriched biological processes (BP) in the
fetal brain during the last stage of gestation. These BP were significantly
enriched with the co-expressed genes forming part of the top modules
with highest positive correlation with fetal age in each of the ovine fetal
brain regions (i.e., strongly increasing in expression toward the first day of
extra-uterine life).
Additional file 7: Figure S5. qRT-PCR validation for CD34, CD109,
CD44, CD5 and CD9. Gene expression of CD34, CD109, CD44, CD5 and
CD9 measured by microarray at 80, 100, 120, 130, 145 days of gestation
and 1 day of extra-uterine life and corresponding fold changes in mRNA
concentration relative to 80 days, measured by qRT- PCR in samples from
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at 80d. a - different from 80d values; b - different from 100d values; c -
different from 120d values; d - different from 130d values; e - different from
145d values; f – different from 1d of extra-uterine life values. For all statistical
comparisons, P < 0.05 was used as the criterion for significance.
Additional file 8: Figure S6. qRT-PCR validation for CSF1R, CSF1, IL34,
CD11b and CD81. Gene expression of CSF1R, CSF1, IL34, CD11b and CD81
measured by microarray at 80, 100, 120, 130, 145 days of gestation and
1 day of extra-uterine life and corresponding fold changes in mRNA
concentration relative to 80 days, measured by qRT- PCR in samples from
ovine fetal cortex. Data are fold differences relative to mean expression at
80d. a - different from 80d values; b - different from 100d values; c - different
from 120d values; d - different from 130d values; e - different from 145d
values. For all statistical comparisons, P < 0.05 was used as the criterion for
significance.
Additional file 9: Figure S7. qRT-PCR validation for CD3G, CD3D and
CD3E. Gene expression of CD3G, CD3D and CD3E measured by microarray
at 80, 100, 120, 130, 145 days of gestation and 1 day of extra-uterine life and
corresponding fold changes in mRNA concentration relative to 80 days,
measured by qRT- PCR in samples from ovine fetal hippocampus. Data are
fold differences relative to mean expression at 80d. a - different from 80d
values; b - different from 100d values; c - different from 120d values;
d - different from 130d values; e - different from 145d values. For all
statistical comparisons, P < 0.05 was used as the criterion for significance.
Additional file 10: Figure S8. qRT-PCR validation for MBP, CD24,
FGRIIB, IL10, and TGFB. Gene expression of MBP (A), CD24 (B) and FGRIIB,
IL10, TGFB (C) measured by microarray at 80, 100, 120, 130, 145 days of
gestation and 1 day of extra-uterine life and corresponding fold changes
in mRNA concentration relative to 80 days, measured by qRT- PCR in
samples from ovine fetal cortex. Data are fold differences relative to mean
expression at 80d. a - different from 80d values; b - different from 100d
values; c - different from 120d values; d - different from 130d values;
e - different from 145d values. For all statistical comparisons, P < 0.05 was
used as the criterion for significance.
Additional file 11: Table S3. Sequences of primers and probes for
real-time PCR analysis.Competing interests
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